As an public company, NGIO will begin to incur costs for corporate activities such as executives, corporate accounting for external reporting, and investor relations. Reasonable estimates of such costs are not available.
Now! Lets go to Nasdaq!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links